Insomnia Global Clinical Trials Review, H2, 2014

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Insomnia Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/750234/Insomnia-Global-Clinical-Trials-Review-H2-2014.html

Insomnia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Insomnia Global Clinical Trials Review, H2, 2014" provides data on the Insomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insomnia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Insomnia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Introduction 6
Insomnia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Insomnia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Insomnia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Insomnia 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Insomnia Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Takeda Pharmaceutical Company Limited 34
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 34
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Dainippon Sumitomo Pharma Co., Ltd. 39
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 39
Sanofi 41
Clinical Trial Overview of Sanofi 41
Neurocrine Biosciences, Inc. 43
Clinical Trial Overview of Neurocrine Biosciences, Inc. 43
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Neurim Pharmaceuticals Ltd 48
Clinical Trial Overview of Neurim Pharmaceuticals Ltd 48
Eisai Co., Ltd. 49
Clinical Trial Overview of Eisai Co., Ltd. 49
Actelion Ltd 50
Clinical Trial Overview of Actelion Ltd 50
Clinical Trial Overview of Top Institutes / Government 51
University of Rochester 51
Clinical Trial Overview of University of Rochester 51
Duke University 52
Clinical Trial Overview of Duke University 52
U.S. Department of Veterans Affairs 53
Clinical Trial Overview of U.S. Department of Veterans Affairs 53
Karolinska Institute 54
Clinical Trial Overview of Karolinska Institute 54
University of Pittsburgh 55
Clinical Trial Overview of University of Pittsburgh 55
Brigham and Women's Hospital 56
Clinical Trial Overview of Brigham and Women's Hospital 56
Stanford University 57
Clinical Trial Overview of Stanford University 57
The University of Hong Kong 58
Clinical Trial Overview of The University of Hong Kong 58
Massachusetts General Hospital 59
Clinical Trial Overview of Massachusetts General Hospital 59
National Institute of Mental Health 60
Clinical Trial Overview of National Institute of Mental Health 60
Five Key Clinical Profiles 61
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 110


List of Tables

Insomnia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Insomnia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Insomnia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Insomnia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Insomnia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Insomnia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Insomnia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Insomnia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Insomnia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Insomnia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Insomnia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Insomnia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Insomnia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Insomnia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Insomnia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Insomnia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Insomnia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Insomnia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Insomnia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Insomnia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Insomnia Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Insomnia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Insomnia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Insomnia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Insomnia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Insomnia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 34
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 37
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dainippon Sumitomo Pharma Co., Ltd., 2014* 39
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 41
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2014* 43
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 45
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 47
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurim Pharmaceuticals Ltd, 2014* 48
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 49
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 50
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 51
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 52
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 53
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014* 54
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 55
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 56
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 57
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 58
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 59
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 60


List of Figures

Insomnia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Insomnia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Insomnia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Insomnia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Insomnia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Insomnia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Insomnia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Insomnia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Insomnia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Insomnia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Insomnia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Insomnia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Insomnia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Insomnia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Insomnia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Insomnia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Insomnia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Insomnia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Insomnia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Insomnia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Insomnia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Insomnia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Insomnia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 109


Read the full report:
Insomnia Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/750234/Insomnia-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer